» Articles » PMID: 15825309

Interaction of Clindamycin and Gentamicin in Vitro

Overview
Specialty Pharmacology
Date 1974 Nov 1
PMID 15825309
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The minimal inhibitory concentrations of clindamycin and gentamicin alone and in combinations were determined by a microdilution method for 163 aerobic, facultative, and anaerobic clinical isolates. All 77 strains of Staphylococcus aureus, Diplococcus pneumoniae, Streptococcus pyogenes, and anaerobic bacteria (except for three strains of Clostridium) were inhibited by 1.6 mug or less of clindamycin per ml. Gentamicin did not interfere with the activity of clindamycin within the range of concentrations tested (0.1 to 100 mug/ml); for some strains combinations were synergistic. Sixty-two (94%) of 66 strains of Enterobacteriaceae and Pseudomonas aeruginosa were inhibited by 6.2 mug or less of gentamicin per ml. Combinations of clindamycin and gentamicin were indifferent for 29 strains and synergistic for 33 strains. All 20 strains of enterococcus, three strains of Clostridium, three strains of Escherichia coli, and one strain of Proteus rettgeri were resistant to both clindamycin (minimal inhibitory concentration greater than 3.1 mug/ml) and gentamicin (minimal inhibitory concentration greater than 6.2 mug/ml). Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. Except for clindamycin-sensitive isolates, synergy was usually observed only at concentrations of one or both drugs which are not readily obtainable in vivo. Antagonism was never observed.

Citing Articles

Potentiating antibiotics in drug-resistant clinical isolates via stimuli-activated superoxide generation.

Courtney C, Goodman S, Nagy T, Levy M, Bhusal P, Madinger N Sci Adv. 2017; 3(10):e1701776.

PMID: 28983513 PMC: 5627983. DOI: 10.1126/sciadv.1701776.


Antibiotic-impregnated heart valve sewing rings for treatment and prophylaxis of bacterial endocarditis.

Cimbollek M, Nies B, Wenz R, Kreuter J Antimicrob Agents Chemother. 1996; 40(6):1432-7.

PMID: 8726015 PMC: 163345. DOI: 10.1128/AAC.40.6.1432.


Antimicrobial drugs used in the management of anaerobic infections in children.

Brook I Drugs. 1983; 26(6):520-9.

PMID: 6360636 DOI: 10.2165/00003495-198326060-00004.


Inconsistency of synergy between the beta-lactamase inhibitor CP-45,899 and beta-lactam antibiotics against multiply drug-resistant Enterobacteriaceae and pseudomonas species.

Fass R Antimicrob Agents Chemother. 1981; 19(2):361-3.

PMID: 6289732 PMC: 181432. DOI: 10.1128/AAC.19.2.361.


Treatment of infections caused by ampicillin-resistant pathogens with a combination of ampicillin and CP-45,899.

Plouffe J Antimicrob Agents Chemother. 1982; 21(3):519-20.

PMID: 6285812 PMC: 181928. DOI: 10.1128/AAC.21.3.519.


References
1.
Cox C . Gentamicin. Med Clin North Am. 1970; 54(5):1305-15. View

2.
Sutter V, Finegold S . Antibiotic disc susceptibility tests for rapid presumptive identification of Gram-negative anaerobic bacilli. Appl Microbiol. 1971; 21(1):13-20. PMC: 377108. DOI: 10.1128/am.21.1.13-20.1971. View

3.
Fass R, Scholand J, Hodges G, SASLAW S . Clindamycin in the treatment of serious anaerobic infections. Ann Intern Med. 1973; 78(6):853-9. DOI: 10.7326/0003-4819-78-6-853. View

4.
Fass R, SASLAW S . Clindamycin: clinical and laboratory evaluation of parenteral therapy. Am J Med Sci. 1972; 263(5):368-82. View

5.
Richards F, McCall C, Cox C . Gentamicin treatment of staphylococcal infections. JAMA. 1971; 215(8):1297-300. View